Gilead Sciences (GILD) Announces U.S. FDA Approves Descovy for HIV Pre-Exposure Prophylaxis

October 3, 2019 2:49 PM
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a pre-exposure prophylaxis (PrEP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles